Back

Impact of COVID-19 lockdowns on STEMI percutaneous interventions

29 August 2021 (20:33 - 20:42)
Organised by:
Congress Presentation Part of: COVID-19 and percutaneous intervention Outcome ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Doctor Viviana Zlochiver

Advocate Aurora Health Centre, Milwaukee (United States of America)

3 More presentations in this session

Presentation thumbnail
Assessment of vascular endothelial function in COVID-19 patients
Doctor H. Mejia Renteria (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Soluble urokinase-type plasminogen activator receptor (suPAR) is associated with risk for thromboembolic complications and mortality in patients with COVID-19
Doctor S. Luo (Baltimore, US)
Abstract Slides Video
Presentation thumbnail
Stroke mechanisms associated with coronavirus disease (COVID-19)
Professor M. Kruchinina (Novosibirsk, RU)
Abstract Slides Video

Access the full session

Session thumbnail
COVID-19 and percutaneous intervention

The Event

Event poster

ESC Congress 2021 - The Digital Experience

29 August 2021 20:33 CET
You may be interested in
thumbnail
Congress Presentation
Effects of percutaneous coronary intervention on improvement of left ventricular ejection fraction among chronic coronary syndrome patients with left ventricular systolic dysfunction
thumbnail
Congress Presentation
Percutaneous coronary revascularization timing in patients undergoing transcatheter aortic valve implantation
thumbnail
Congress Presentation
Percutaneous coronary intervention versus optimal medical therapy for chronic total occlusion: an updated meta-analysis of randomized controlled trials comparing clinical and health status outcomes

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources